AstraZeneca Plc said on Sunday Britain's health regulator had started an accelerated review of its potential coronavirus vaccine - Reuters reports.
"We confirm the MHRA's (Medicines and Healthcare Products Regulatory Agency) rolling review of our potential COVID-19 vaccine," - Reuters quoted AstraZeneca spokesman.
The British drug maker said on Monday its COVID-19 experimental vaccine produces an immune response in both old and young adults. The vaccine also triggers lower adverse responses among the elderly, it said, according to Reuters.
